JPRN-UMIN000001992已完成未知
Effects of risedronate and alfacalcidol on parameters of atherosclerosis in type 2 diabetes patients with osteoporosis - Effects of risedronate and alfacalcidol on parameters of atherosclerosis
Department of Internal Medicine 1, Shimane University School of Medicine0 个研究点目标入组 40 人开始时间: 2009年5月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
After 1 year treatment with risedronate and alfacalcidol, plaque score and abdominal aortic calcification score in the osteoporosis group were not statistically changed, while both two parameters in the control group were significantly increased
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Nobody had hepatic or renal dysfunction or nutritional derangements. All patients were free of drugs known to influence bone and calcium metabolism, such as vitamin D, bisphosphonate, or estrogen, up until the time of the study.
研究者
相似试验
已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuria.Alkaptonuria.NL-OMON28328MC Utrecht6
已完成
不适用
Combination therapy of Eldecalcitol with Risedronate on Aromatase inhibitor treated post-operative Mammary carcinoma In the prevention of bone QUality and quantity Exacerbation (CERAMIQUE) randomized trialSecondary osteoporosisJPRN-UMIN000008286Osaka City University Graduate School of Medicine200
已完成
不适用
CERAMIQUE trialsecondary osteoporosismammary carcinomaJPRN-jRCTs051180179Imanishi Yasuo200
进行中（未招募）
不适用
Effects of generic risedronate on bone turnover markers and bone mineral density in Thai postmenopausal osteoporosis.postmenopausal womenBone turnover markersrisedronateBMDosteoporosisTCTR20240427002Ratchadapisek Research Funds80
已完成
不适用
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or RisedronatePostmenopausal OsteoporosisNCT00778154Warner Chilcott105